Consistent with our finding that miR-197 can regulate chemoresistance, our results further suggested that PD-L1 is a biomarker of the miR-197/CKS1B/STAT3-mediated cascade in NSCLC. This evidence concerns the gene CD274 and non-small cell lung carcinoma.